A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

Onkovis

Status: Completed

Conditions: Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT01840280

ONKOIRI01

Details and patient eligibility

About

The main purpose of this observational study with Irinotecan onkovis is to determine the number of treatment cycles and the quantity of Irinotecan onkovis needed for this purpose under the special circumstances of ambulant chemotherapy.

Onkovis aims to contribute to an economical utilization of the chemotherapeutics. This includes provision of appropriate packaging sizes to decrease the excess quantity to be discarded, and thus also follows this objective.

Secondary objective is the assessment of the side effects of Irinotecan onkovis. To this end, data regarding co-medication and adverse events are also collected.

Enrollment: 324 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Indication for Irinotecan according to the SmPC and treating physician

Exclusion criteria

• according to the Irinotecan SmPC

Trial design

324 participants in 1 patient group

Carcinoma, Irinotecan onkovis (Irinotecan)

Description:

Treatment in mono- or combination therapy with Irinotecan of advanced colorectal carcinoma.